Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇰🇷KR · Science#8410K to 30K
- 🇮🇪IE · Science#153500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
5.3K to 17K🎙 Weekly cadence·39 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
11K to 33K🇰🇷91%🇮🇪9% - Active Followers
Loyal subscribers who consistently listen
3.1K to 9.9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHosts
Recent guests
Recent episodes
ImmunoTea Episode 43 - Microplastics and the Immune System
Jul 19, 2026
35m 51s
ImmunoTea Episode 42 - The Non-Infectious Complications of CVID
Jun 14, 2026
31m 43s
ImmunoTea Episode 41 - Systems Immunology
May 17, 2026
40m 09s
ImmunoTea Episode 40 - Chronic Infections in Inborn Errors of Immunity
Apr 19, 2026
37m 33s
ImmunoTea Episode 39 - The Immunology of Pregnancy
Mar 16, 2026
37m 12s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/19/26 | microplasticsimmune system+3 | Prof Michaela Lucas | University of Western Australia | — | microplasticsimmune system+3 | — | 35m 51s | ||
| 6/14/26 | common variable immunodeficiencynon-infectious complications+1 | Dr Smita Patel | University of Oxford | — | CVIDimmunodeficiency+3 | — | 31m 43s | ||
| 5/17/26 | human immune systemsimmune networks+3 | Professor Petter Brodin | Karolinska Institute | — | immunologyimmune systems+4 | — | 40m 09s | ||
| 4/19/26 | chronic infectionsinborn errors of immunity+3 | Dr David Lowe | Royal Free HospitalImmunoTea+1 | — | chronic infectionsinborn errors of immunity+3 | — | 37m 33s | ||
| 3/16/26 | immunologypregnancy+3 | Dr Sylvie Girard | Mayo Clinic | Rochester, Minnesota | immunologypregnancy+3 | — | 37m 12s | ||
| 2/16/26 | T cell engaging immunotherapiesCAR T-cells+3 | Prof Georg Schett | Friedrich-Alexander University | — | T cellimmunotherapy+3 | — | 42m 57s | ||
| 1/19/26 | Precision DiagnosticsImmunology+3 | Professor Alex Richter | University of Birmingham | — | immunologyprecision diagnostics+3 | — | 35m 01s | ||
| 12/15/25 | immunological drug developmentimmune system+3 | Dr Anish Suri | — | — | immunologydrug development+3 | — | 37m 01s | ||
| 11/19/25 | mast cell disordersimmunology+3 | Dr Frank Siebenhaar | Charité University Hospital Berlin | — | mast cellsimmunology+3 | — | 1h 00m 10s | ||
| 10/19/25 | innate immune systemdisease+3 | Dr Peter Arkwright | University of Manchester | — | innate immune systemdisease+5 | — | 37m 42s | ||
| 9/14/25 | immuno-metabolismcancer+2 | Prof Greg Delgoff | University of Pittsburgh | — | immuno-metabolismcancer treatments+3 | — | 43m 47s | ||
| 8/17/25 | regulatory T cellsneuroinflammatory disease+3 | Prof Adrian Liston | University of Cambridge | — | regulatory T cellsneuroinflammation+3 | — | 38m 01s |
Showing 12 of 12
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for ImmunoTea: Your Immunology Podcast
Peaked at #84 in South Korea, currently #84 in South Korea.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| South Korea | — | #84 | #84 | — |
| Ireland | — | #153 | #153 | — |
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.